The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 09, 2024
Filed:
Mar. 24, 2017
Applicant:
Cothera Bioscience, Inc., Grand Cayman, KY;
Inventors:
Thomas M. Estok, Williamsburg, VA (US);
Eckard Weber, San Diego, CA (US);
Tracy Lee Lawhon, San Diego, CA (US);
Assignee:
COTHERA BIOSCIENCE, INC., Grand Cayman, KY;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/529 (2006.01); A61P 35/00 (2006.01); A61K 33/243 (2019.01); A61K 31/44 (2006.01); A61K 31/454 (2006.01); A61K 31/495 (2006.01); A61K 31/69 (2006.01); A61K 31/704 (2006.01); A61K 38/07 (2006.01); A61K 39/395 (2006.01);
U.S. Cl.
CPC ...
A61K 31/529 (2013.01); A61K 31/44 (2013.01); A61K 31/454 (2013.01); A61K 31/495 (2013.01); A61K 31/69 (2013.01); A61K 31/704 (2013.01); A61K 33/243 (2019.01); A61K 38/07 (2013.01); A61K 39/3955 (2013.01); A61P 35/00 (2018.01);
Abstract
The present disclosure provides therapeutic methods of treating a cancer patient with TG02 and a second therapeutic agent, e.g., TG02 and an immune checkpoint inhibitor, TG02 and a COX-2 inhibitor, or TG02 and an immune checkpoint inhibitor and a COX-2 inhibitor.